Comment on

• A prospective randomized trial comparing 6 versus 12 prostate biopsy cores: impact on cancer detection.

  Naughton CK, Miller DC, Mager DE, Ornstein DK, Catalona WJ. Naughton CK, et al. J Urol. 2000 Aug;164(2):388-92. J Urol. 2000. PMID: 10893592 Clinical Trial.
• Extensive biopsy protocol improves the detection rate of prostate cancer.

  Ravery V, Goldblatt L, Royer B, Blanc E, Toublanc M, Boccon-Gibod L. Ravery V, et al. J Urol. 2000 Aug;164(2):393-6. J Urol. 2000. PMID: 10893593
• A randomized prospective trial of intrarectal lidocaine for pain control during transrectal prostate biopsy: the Emory University experience.

  Issa MM, Bux S, Chun T, Petros JA, Labadia AJ, Anastasia K, Miller LE, Marshall FF. Issa MM, et al. J Urol. 2000 Aug;164(2):397-9. J Urol. 2000. PMID: 10893594 Clinical Trial.
• Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology.

  Wefer AE, Hricak H, Vigneron DB, Coakley FV, Lu Y, Wefer J, Mueller-Lisse U, Carroll PR, Kurhanewicz J. Wefer AE, et al. J Urol. 2000 Aug;164(2):400-4. J Urol. 2000. PMID: 10893595